Pub Date : 2023-12-01Epub Date: 2023-12-11DOI: 10.1080/1354750X.2023.2277668
Mariam M Abd El-Azim, Mona K Mousa, Ragaa M Abdelmaaboud, Nabil N Rezq, Sarah S Mohammed
Background: This study aimed to assess the predictive value of NLR, PLR, and MPV time series for diagnosis and prognosis of hemotoxic snakebite envenomation.
Methods: This is a prospective study among snakebite patients admitted to the Poison Control Center of Ain Shams University Hospitals and Assiut University Hospitals from the beginning of July 2019 to the end of October 2021. Patients were classified according to their clinical severity into three groups: mild, moderate, and severe.
Results: The maximum incidence of snakebite was found in males (95%) from rural areas (80%); at lower limbs (70%); at night (51%); and during the autumn season (43.3%). The admission NLR and PLR can predict hemotoxic snakebite envenomation with an AUC of 0.940 and 0.569. The combination of NLR with PLR can develop a more predominant prediction of snakebite envenomation with an area under the curve (AUC) of 0.979. Furthermore, higher admission NLR and PLR levels are associated with prolonged hospital stays.
Conclusion: While NLR and PLR levels may be helpful in the diagnosis of snakebite, MPV plays no part in the prognosis of snakebite patients. Serial NLR, PLR initially, at 24 hours, and predischarge can be used to evaluate the early treatment response.
{"title":"Evaluation of the role of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and mean platelet volume (MPV) time series as predictors of diagnosis and prognosis of hemotoxic snakebite.","authors":"Mariam M Abd El-Azim, Mona K Mousa, Ragaa M Abdelmaaboud, Nabil N Rezq, Sarah S Mohammed","doi":"10.1080/1354750X.2023.2277668","DOIUrl":"10.1080/1354750X.2023.2277668","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to assess the predictive value of NLR, PLR, and MPV time series for diagnosis and prognosis of hemotoxic snakebite envenomation.</p><p><strong>Methods: </strong>This is a prospective study among snakebite patients admitted to the Poison Control Center of Ain Shams University Hospitals and Assiut University Hospitals from the beginning of July 2019 to the end of October 2021. Patients were classified according to their clinical severity into three groups: mild, moderate, and severe.</p><p><strong>Results: </strong>The maximum incidence of snakebite was found in males (95%) from rural areas (80%); at lower limbs (70%); at night (51%); and during the autumn season (43.3%). The admission NLR and PLR can predict hemotoxic snakebite envenomation with an AUC of 0.940 and 0.569. The combination of NLR with PLR can develop a more predominant prediction of snakebite envenomation with an area under the curve (AUC) of 0.979. Furthermore, higher admission NLR and PLR levels are associated with prolonged hospital stays.</p><p><strong>Conclusion: </strong>While NLR and PLR levels may be helpful in the diagnosis of snakebite, MPV plays no part in the prognosis of snakebite patients. Serial NLR, PLR initially, at 24 hours, and predischarge can be used to evaluate the early treatment response.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"652-662"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2023-12-11DOI: 10.1080/1354750X.2023.2276030
Deepak Bhandari, Yuyang Zhu, Can Zhang, Wanzhe Zhu, Apostolos Alexandridis, Arash Etemadi, Neal D Freedman, Cindy Chang, Christian C Abnet, Sanford M Dawsey, Maki Inoue-Choi, Hossein Poustchi, Akram Pourshams, Paolo Boffetta, Reza Malekzadeh, Benjamin Blount
Background. Benzene is a known human carcinogen. Human exposure to benzene can be assessed by measuring trans, trans-muconic acid (MUCA) in urine. Golestan Province in northeastern Iran has been reported to have high incidence of esophageal cancer linked to the use of tobacco products. This manuscript evaluates the urinary MUCA concentrations among the participants of the Golestan Cohort Study (GCS).Methods. We analyzed MUCA concentration in 177 GCS participants' urine samples and performed nonparametric pairwise multiple comparisons to determine statistically significant difference among six different product use groups. Mixed effects model was fitted on 22 participants who exclusively smoked cigarette and 51 participants who were classified as nonusers. The urinary MUCA data were collected at the baseline and approximately five years later, and intraclass correlation coefficient (ICC) was calculated from the model.Results. Compared with nonusers, tobacco smoking was associated with higher urinary MUCA concentrations. Based on the nonparametric test of pairwise multiple comparisons, MUCA concentrations among participants who smoked combusted tobacco products were statistically significantly higher compared to nonusers. Urinary MUCA collected five years apart from the same individuals showed moderate reliability (ICC = 0.41), which was expected given the relatively short half-life (∼6 h) of MUCA.Conclusion. Our study revealed that tobacco smoke was positively associated with increased levels of urinary MUCA concentration, indicating that it is a significant source of benzene exposure among GCS participants.
{"title":"Smoke exposure associated with higher urinary benzene biomarker muconic acid (MUCA) in Golestan Cohort Study participants.","authors":"Deepak Bhandari, Yuyang Zhu, Can Zhang, Wanzhe Zhu, Apostolos Alexandridis, Arash Etemadi, Neal D Freedman, Cindy Chang, Christian C Abnet, Sanford M Dawsey, Maki Inoue-Choi, Hossein Poustchi, Akram Pourshams, Paolo Boffetta, Reza Malekzadeh, Benjamin Blount","doi":"10.1080/1354750X.2023.2276030","DOIUrl":"10.1080/1354750X.2023.2276030","url":null,"abstract":"<p><p><b>Background</b>. Benzene is a known human carcinogen. Human exposure to benzene can be assessed by measuring <i>trans, trans</i>-muconic acid (MUCA) in urine. Golestan Province in northeastern Iran has been reported to have high incidence of esophageal cancer linked to the use of tobacco products. This manuscript evaluates the urinary MUCA concentrations among the participants of the Golestan Cohort Study (GCS).<b>Methods</b>. We analyzed MUCA concentration in 177 GCS participants' urine samples and performed nonparametric pairwise multiple comparisons to determine statistically significant difference among six different product use groups. Mixed effects model was fitted on 22 participants who exclusively smoked cigarette and 51 participants who were classified as nonusers. The urinary MUCA data were collected at the baseline and approximately five years later, and intraclass correlation coefficient (ICC) was calculated from the model.<b>Results.</b> Compared with nonusers, tobacco smoking was associated with higher urinary MUCA concentrations. Based on the nonparametric test of pairwise multiple comparisons, MUCA concentrations among participants who smoked combusted tobacco products were statistically significantly higher compared to nonusers. Urinary MUCA collected five years apart from the same individuals showed moderate reliability (ICC = 0.41), which was expected given the relatively short half-life (∼6 h) of MUCA.<b>Conclusion.</b> Our study revealed that tobacco smoke was positively associated with increased levels of urinary MUCA concentration, indicating that it is a significant source of benzene exposure among GCS participants.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"637-642"},"PeriodicalIF":2.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11323030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50160549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2024-01-22DOI: 10.1080/1354750X.2023.2298182
Thiago Guedes Pinto, Daniel Vitor de Souza, Glenda Nicioli da Silva, Daisy Maria Favero Salvadori, Manoela Domingues Martins, Daniel Araki Ribeiro
Background and objectives: In order to detect genetic damage, different methods have been developed, such as micronuclei and comet assay. The comet assay presents some advantages when compared to the other aforementioned methods, including wide versatility, as any eukaryotic cell can be evaluated at an individual cellular level. In this context, the aim of this systematic review was designed to help further elucidate the following question: is the comet assay a suitable biomarker of in vivo oral carcinogenesis?
Material and methods: The present systematic review was performed in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. Full manuscripts from 18 studies were carefully selected in this setting.
Results: A total of 15 studies demonstrated positive findings for genotoxicity in peripheral blood or oral cells in patients with pre-malignant lesions or oral cancer. In the quality assessment of studies, 1 was classified as Strong, 5 were considered as Moderate, and 12 were classified as Weak.
Conclusion: In summary, the comet assay can be a useful biomarker for oral carcinogenesis. However, further studies with more strict parameters are suggested (with less uncontrolled confounders) in order to increase findings reliability for diagnosis of oral potentially malignant lesions.
背景和目的:为了检测基因损伤,人们开发了不同的方法,如微核检测和彗星检测。与上述其他方法相比,彗星试验具有一些优势,包括用途广泛,可在单个细胞水平上对任何真核细胞进行评估。在此背景下,本系统综述旨在帮助进一步阐明以下问题:彗星试验是否是体内口腔癌发生的合适生物标志物? 材料与方法:本系统综述根据《系统综述和荟萃分析首选报告项目》(Preferred Reporting Items for Systematic Review and Meta-Analyses,PRISMA)指南进行。在此背景下,对 18 项研究的完整手稿进行了仔细筛选:结果:共有 15 项研究显示,恶性肿瘤前病变或口腔癌患者外周血或口腔细胞中的基因毒性结果呈阳性。在对研究进行质量评估时,1 项研究被评为 "强",5 项研究被评为 "中",12 项研究被评为 "弱":总之,彗星试验可以作为口腔癌发生的有用生物标志物。结论:总之,彗星测定是口腔癌发生的有用生物标志物,但建议进一步研究更严格的参数(减少未控制的混杂因素),以提高结果对诊断口腔潜在恶性病变的可靠性。
{"title":"Comet assay as a suitable biomarker for <i>in vivo</i> oral carcinogenesis: a systematic review.","authors":"Thiago Guedes Pinto, Daniel Vitor de Souza, Glenda Nicioli da Silva, Daisy Maria Favero Salvadori, Manoela Domingues Martins, Daniel Araki Ribeiro","doi":"10.1080/1354750X.2023.2298182","DOIUrl":"10.1080/1354750X.2023.2298182","url":null,"abstract":"<p><strong>Background and objectives: </strong>In order to detect genetic damage, different methods have been developed, such as micronuclei and comet assay. The comet assay presents some advantages when compared to the other aforementioned methods, including wide versatility, as any eukaryotic cell can be evaluated at an individual cellular level. In this context, the aim of this systematic review was designed to help further elucidate the following question: is the comet assay a suitable biomarker of <i>in vivo</i> oral carcinogenesis?</p><p><strong>Material and methods: </strong>The present systematic review was performed in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guidelines. Full manuscripts from 18 studies were carefully selected in this setting.</p><p><strong>Results: </strong>A total of 15 studies demonstrated positive findings for genotoxicity in peripheral blood or oral cells in patients with pre-malignant lesions or oral cancer. In the quality assessment of studies, 1 was classified as Strong, 5 were considered as Moderate, and 12 were classified as Weak.</p><p><strong>Conclusion: </strong>In summary, the comet assay can be a useful biomarker for oral carcinogenesis. However, further studies with more strict parameters are suggested (with less uncontrolled confounders) in order to increase findings reliability for diagnosis of oral potentially malignant lesions.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"692-702"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138828128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2023-09-10DOI: 10.1080/1354750X.2023.2255756
M Morales-Velásquez, J P Barón-Vera, M I Pulgarín-Osorio, M M Sánchez-Jiménez, J D Ospina-Villa
Background: Chagas disease (CD) is considered by the World Health Organisation (WHO) a neglected disease endemic to the Americas, but it has spread throughout the world due to migrations. The disease is almost 100% curable if detected in time. Still, the lack of rapid diagnostic tests with sufficient sensitivity and specificity leads to a chronic phase with a mortality of about 50,000 people worldwide per year.
Methods: Using the total proteins extracted from serum samples of patients confirmed with chronic phase CD; we performed the Bio-SELEX strategy. The best aptamers were selected using next-generation sequencing (NGS) based on their most abundant sequences (reads and rpm). Then, selected aptamers were used to isolate potential biomarkers directly from serum samples of patients with chronic phase CD using pull-down and mass spectrometry experiments.
Results: CH1 aptamer was the aptamer selected after the NGS results analysis. The pull-down and mass spectrometry experiments identified the presence of the ATPase alpha subunit of T. cruzi circulating in serum samples of patients with chronic phase CD.
Conclusions: We report the ATPase alpha subunit of T. cruzi as a potential biomarker for chronic phase CD and CH1 aptamer as a potential tool for diagnosing CD.
背景:世界卫生组织(WHO)认为南美锥虫病(CD)是一种在美洲流行的被忽视的疾病,但由于人口迁移,这种疾病已蔓延到世界各地。如果及时发现,这种疾病几乎 100%可以治愈。然而,由于缺乏具有足够灵敏度和特异性的快速诊断检测方法,导致该病进入慢性阶段,全世界每年约有 50,000 人因此而死亡:方法:我们使用从确诊为慢性期 CD 患者的血清样本中提取的总蛋白,采用 Bio-SELEX 策略。根据最丰富的序列(读数和转数),使用新一代测序技术(NGS)筛选出最佳的适配体。然后,利用牵引和质谱实验从慢性期 CD 患者的血清样本中直接分离出潜在的生物标记物:结果:经过 NGS 结果分析,CH1 合体被选中。结果:经过 NGS 结果分析,我们选择了 CH1 aptamamer 作为适配体,并通过牵引和质谱实验确定了慢性期 CD 患者血清样本中循环存在 T. cruzi 的 ATPase alpha 亚基:我们报告了克鲁兹绦虫的 ATPase alpha 亚基是慢性期 CD 的潜在生物标志物,而 CH1 aptamer 则是诊断 CD 的潜在工具。
{"title":"Identification of the ATPase alpha subunit of <i>Trypanosoma cruzi</i> as a potential biomarker for the diagnosis of Chagas disease.","authors":"M Morales-Velásquez, J P Barón-Vera, M I Pulgarín-Osorio, M M Sánchez-Jiménez, J D Ospina-Villa","doi":"10.1080/1354750X.2023.2255756","DOIUrl":"10.1080/1354750X.2023.2255756","url":null,"abstract":"<p><strong>Background: </strong>Chagas disease (CD) is considered by the World Health Organisation (WHO) a neglected disease endemic to the Americas, but it has spread throughout the world due to migrations. The disease is almost 100% curable if detected in time. Still, the lack of rapid diagnostic tests with sufficient sensitivity and specificity leads to a chronic phase with a mortality of about 50,000 people worldwide per year.</p><p><strong>Methods: </strong>Using the total proteins extracted from serum samples of patients confirmed with chronic phase CD; we performed the Bio-SELEX strategy. The best aptamers were selected using next-generation sequencing (NGS) based on their most abundant sequences (reads and rpm). Then, selected aptamers were used to isolate potential biomarkers directly from serum samples of patients with chronic phase CD using pull-down and mass spectrometry experiments.</p><p><strong>Results: </strong>CH1 aptamer was the aptamer selected after the NGS results analysis. The pull-down and mass spectrometry experiments identified the presence of the ATPase alpha subunit of <i>T. cruzi</i> circulating in serum samples of patients with chronic phase CD.</p><p><strong>Conclusions: </strong>We report the ATPase alpha subunit of <i>T. cruzi</i> as a potential biomarker for chronic phase CD and CH1 aptamer as a potential tool for diagnosing CD.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"599-607"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10251957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2024-01-22DOI: 10.1080/1354750X.2023.2284122
Tobias Schreiber, Jana Grune, Ulf Landmesser, Philipp Attanasio
Introduction: Multiple pathophysiological mechanisms are involved in the pathogenesis of atrial fibrillation (AF). Growing evidence suggests that both local and systemic inflammation plays a key role even in early stages and its progression towards persisting and permanent AF. Rhythm control therapy via pulmonary vein isolation or cardioversion is the cornerstone of AF therapy for most symptomatic patients, yet arrhythmia recurrence after treatment is still common, especially in patients with persistent AF.
Material and methods: In this review, we summarize the current state of knowledge of biomarkers of inflammation with prognostic value in patients with atrial fibrillation as well as anti-inflammatory medication with potential benefits after rhythm control therapy.
Results and discussion: Both onset of AF, progression and arrhythmia recurrence after rhythm control therapy can be caused by local and systemic inflammation. Various inflammatory biomarkers have been established to predict treatment success. Furthermore, additional anti-inflammatory therapy may significantly improve success rates.
{"title":"Detection and modification of biomarkers of inflammation determining successful rhythm control in patients with atrial fibrillation.","authors":"Tobias Schreiber, Jana Grune, Ulf Landmesser, Philipp Attanasio","doi":"10.1080/1354750X.2023.2284122","DOIUrl":"10.1080/1354750X.2023.2284122","url":null,"abstract":"<p><strong>Introduction: </strong>Multiple pathophysiological mechanisms are involved in the pathogenesis of atrial fibrillation (AF). Growing evidence suggests that both local and systemic inflammation plays a key role even in early stages and its progression towards persisting and permanent AF. Rhythm control therapy via pulmonary vein isolation or cardioversion is the cornerstone of AF therapy for most symptomatic patients, yet arrhythmia recurrence after treatment is still common, especially in patients with persistent AF.</p><p><strong>Material and methods: </strong>In this review, we summarize the current state of knowledge of biomarkers of inflammation with prognostic value in patients with atrial fibrillation as well as anti-inflammatory medication with potential benefits after rhythm control therapy.</p><p><strong>Results and discussion: </strong>Both onset of AF, progression and arrhythmia recurrence after rhythm control therapy can be caused by local and systemic inflammation. Various inflammatory biomarkers have been established to predict treatment success. Furthermore, additional anti-inflammatory therapy may significantly improve success rates.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"681-691"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92152603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2023-12-11DOI: 10.1080/1354750X.2023.2269320
Joana M O Santos, Valéria Tavares, Rui M Gil da Costa, Rui Medeiros
Introduction: High-risk human papillomavirus (HPV) is the aetiological agent of cervical cancer, which remains the fourth leading cause of cancer death in women worldwide. K14-HPV16 transgenic mice are a model for HPV-induced cancers, which undergo multistep squamous carcinogenesis at the skin, that is histologically and molecularly similar to carcinogenesis of the human cervix. Previous screens of differentially regulated microRNAs (miRs) using K14-HPV16 mice showed a role for miR-21, miR-155, miR-150, miR-146a, miR-125b and miR-223 during carcinogenesis.
Methods: We now aim to translate these observations into the clinical setting, using data provided by The Cancer Genome Atlas (TCGA) to explore whether those microRNAs can influence the survival of cervical cancer patients.
Results: Results showed that low miR-150, miR-155 and miR-146a expression levels in primary tumours were associated with poor overall survival. However, only miR-150 and miR-155 were found to be independent predictors, increasing the risk of death. When patients were stratified by clinical stage, low miR-150, miR-155, miR-146a and miR-125b were associated with poor survival for clinical stages I and II. Only low miR-150 expression increased the death risk.
Conclusion: We conclude that miR-150 and miR-155 may be potentially applied as prognostic biomarkers in cervical cancer patients. However, further investigation is required to determine their applicability.
{"title":"MiR-150 and miR-155 expression predicts survival of cervical cancer patients: a translational approach to novel prognostic biomarkers.","authors":"Joana M O Santos, Valéria Tavares, Rui M Gil da Costa, Rui Medeiros","doi":"10.1080/1354750X.2023.2269320","DOIUrl":"10.1080/1354750X.2023.2269320","url":null,"abstract":"<p><strong>Introduction: </strong>High-risk human papillomavirus (HPV) is the aetiological agent of cervical cancer, which remains the fourth leading cause of cancer death in women worldwide. K14-HPV16 transgenic mice are a model for HPV-induced cancers, which undergo multistep squamous carcinogenesis at the skin, that is histologically and molecularly similar to carcinogenesis of the human cervix. Previous screens of differentially regulated microRNAs (miRs) using K14-HPV16 mice showed a role for miR-21, miR-155, miR-150, miR-146a, miR-125b and miR-223 during carcinogenesis.</p><p><strong>Methods: </strong>We now aim to translate these observations into the clinical setting, using data provided by The Cancer Genome Atlas (TCGA) to explore whether those microRNAs can influence the survival of cervical cancer patients.</p><p><strong>Results: </strong>Results showed that low miR-150, miR-155 and miR-146a expression levels in primary tumours were associated with poor overall survival. However, only miR-150 and miR-155 were found to be independent predictors, increasing the risk of death. When patients were stratified by clinical stage, low miR-150, miR-155, miR-146a and miR-125b were associated with poor survival for clinical stages I and II. Only low miR-150 expression increased the death risk.</p><p><strong>Conclusion: </strong>We conclude that miR-150 and miR-155 may be potentially applied as prognostic biomarkers in cervical cancer patients. However, further investigation is required to determine their applicability.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"617-627"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71520385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2023-12-11DOI: 10.1080/1354750X.2023.2268859
Calinca Skonieski, Karina Raquel Fagundes, Larissa da Silva, Hecson Jesser Segat, Anderson Joel Martino Andrade, Rodrigo Cordeiro Bolzan, Mario Hiroyuki Hirata, Glaucio Monteiro Ferreira, Dalila Moter Benvegnú
Introduction: Exposure to pesticides may be related to overweight and associated comorbidities. The aim of this work was to evaluate occupational exposure to pesticides, overweight and associated comorbidities among farmers in Southern Brazil.
Methods: This cross-sectional study included a random sample of 257 farmers, living in the municipality of Mafra and Planalto, southern Brazil. Data on pesticide use and overweight prevalence from farmers were collected using an in-person interview questionnaire, followed by blood collection and biochemical analyses.
Results: Pesticide exposure was positively correlated with body mass index, waist circumference, waist-to-hip ratio, triglycerides and glucose levels, presence of hypertension and metabolic syndrome. Besides that, the fact of being exposed to pesticides represents a decrease of no protein thiol groups. Furthermore, the main pesticides used by farmers have hepatic toxicity.
Conclusion: These findings suggest that exposure to pesticides may be associated with overweight and associated comorbidities. Further studies are required to validate our findings and elucidate the specific mechanisms by which these pollutants contribute to the development of overweight.
{"title":"Association of occupational exposure to pesticides with overweight in farmers in Southern Brazil.","authors":"Calinca Skonieski, Karina Raquel Fagundes, Larissa da Silva, Hecson Jesser Segat, Anderson Joel Martino Andrade, Rodrigo Cordeiro Bolzan, Mario Hiroyuki Hirata, Glaucio Monteiro Ferreira, Dalila Moter Benvegnú","doi":"10.1080/1354750X.2023.2268859","DOIUrl":"10.1080/1354750X.2023.2268859","url":null,"abstract":"<p><strong>Introduction: </strong>Exposure to pesticides may be related to overweight and associated comorbidities. The aim of this work was to evaluate occupational exposure to pesticides, overweight and associated comorbidities among farmers in Southern Brazil.</p><p><strong>Methods: </strong>This cross-sectional study included a random sample of 257 farmers, living in the municipality of Mafra and Planalto, southern Brazil. Data on pesticide use and overweight prevalence from farmers were collected using an in-person interview questionnaire, followed by blood collection and biochemical analyses.</p><p><strong>Results: </strong>Pesticide exposure was positively correlated with body mass index, waist circumference, waist-to-hip ratio, triglycerides and glucose levels, presence of hypertension and metabolic syndrome. Besides that, the fact of being exposed to pesticides represents a decrease of no protein thiol groups. Furthermore, the main pesticides used by farmers have hepatic toxicity.</p><p><strong>Conclusion: </strong>These findings suggest that exposure to pesticides may be associated with overweight and associated comorbidities. Further studies are required to validate our findings and elucidate the specific mechanisms by which these pollutants contribute to the development of overweight.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"608-616"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41181905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2023-12-11DOI: 10.1080/1354750X.2023.2276670
Qiang Li, Yanfei Jia, Bo Tang, Hu Yang, Qiang Yang, Xiaodong Luo, Yawen Pan
Background: Medulloblastoma is the most common malignant brain tumor in children. There are four groups, each with different causal mutations, affected pathways and prognosis. Here, we investigated the role of mitochondria in medulloblastoma and whether there are differences between the different groups.
Methods: We compared the gene expression levels in the four different medulloblastoma groups (MB-WNT, MB-SHH, MB-G3 and MB-G4), with the focus on genes associated with mitochondria. We used several tools including Salmon, Tximeta, DESeq2, BiomaRt, STRING, Ggplot2, EnhancedVolcano, Venny 2.1 and Metscape.
Results: A total of 668 genes were differentially expressed and the most abundant genes were associated with cell division pathway followed by modulation of chemical synaptic transmission. We also identified several genes (ABAT, SOX9, ALDH5A, FOXM1, ABL1, NHLH1, NEUROD1 and NEUROD2) known to play vital role in medulloblastoma. Comparative expression analysis revealed OXPHOS complex-associated proteins of mitochondria. The most significantly expressed genes in the MB-SHH and MB-G4 groups were AHCYL1 and SFXN5 while PAICS was significantly upregulated in MB-WNT group. Notably, MB-G3 contained the most downregulated genes from the OXPHOS complexes, except COX6B2 which was strongly upregulated.
Conclusions: We show the importance of mitochondria and compare their role in the four different medulloblastoma groups.
{"title":"Mitochondrial subtype <i>MB-G3</i> contains potential novel biomarkers and therapeutic targets associated with prognosis of medulloblastoma.","authors":"Qiang Li, Yanfei Jia, Bo Tang, Hu Yang, Qiang Yang, Xiaodong Luo, Yawen Pan","doi":"10.1080/1354750X.2023.2276670","DOIUrl":"10.1080/1354750X.2023.2276670","url":null,"abstract":"<p><strong>Background: </strong>Medulloblastoma is the most common malignant brain tumor in children. There are four groups, each with different causal mutations, affected pathways and prognosis. Here, we investigated the role of mitochondria in medulloblastoma and whether there are differences between the different groups.</p><p><strong>Methods: </strong>We compared the gene expression levels in the four different medulloblastoma groups (MB-WNT, MB-SHH, MB-G3 and MB-G4), with the focus on genes associated with mitochondria. We used several tools including Salmon, Tximeta, DESeq2, BiomaRt, STRING, Ggplot2, EnhancedVolcano, Venny 2.1 and Metscape.</p><p><strong>Results: </strong>A total of 668 genes were differentially expressed and the most abundant genes were associated with cell division pathway followed by modulation of chemical synaptic transmission. We also identified several genes (<i>ABAT</i>, <i>SOX9</i>, <i>ALDH5A</i>, <i>FOXM1</i>, <i>ABL1</i>, <i>NHLH1</i>, <i>NEUROD1</i> and <i>NEUROD2</i>) known to play vital role in medulloblastoma. Comparative expression analysis revealed OXPHOS complex-associated proteins of mitochondria. The most significantly expressed genes in the MB-SHH and MB-G4 groups were <i>AHCYL1</i> and <i>SFXN5</i> while <i>PAICS</i> was significantly upregulated in MB-WNT group. Notably, MB-G3 contained the most downregulated genes from the OXPHOS complexes, except <i>COX6B2</i> which was strongly upregulated.</p><p><strong>Conclusions: </strong>We show the importance of mitochondria and compare their role in the four different medulloblastoma groups.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"643-651"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54227471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2024-01-22DOI: 10.1080/1354750X.2023.2298651
Torgny Wessman, Toralph Ruge, Axel Carl Carlsson, Per Wändell, Ardavan Khoshnood, Olle Melander
Introduction: The aim was to evaluate two biomarker scores trained to identify comorbidity burden in the prediction of specified chronic morbidities, and mortality in the general population.
Methods: Cardiovascular biomarkers were measured in the cardiovascular cohort of the Malmö Diet and Cancer Study. A score of 19 biomarkers associated with Charlson Comorbidity Index (CCI) was created (BSMDC). Individuals with CCI diagnoses and other major comorbidities were excluded. Another score of 11 biomarkers associated with comorbidity burden from a previous study of acute dyspnea was also created (BSADYS). The scores were prospectively evaluated for prediction of mortality, and some chronic diseases, using Cox Proportional Hazards Model.
Results: Fully adjusted models showed that BSMDC was significantly associated per 1 SD increment of the score with incident COPD, 55%, and congestive heart failure, 32%; and with mortality, 33% cardiovascular, 91% respiratory, 30% cancer, and 45% with all-cause mortality. The BSADYS showed no association with these outcomes, after simultaneous inclusion of both biomarker scores to all the clinical covariates.
Conclusion: BSMDC shows strong prediction of morbidity and mortality in individuals free from comorbidities at baseline, and the results suggest that healthy individuals with high level of BSMDC would benefit from intense preventive actions.
{"title":"Relationships between Charlson comorbidity index associated biomarkers and outcomes among participants in the Malmö diet and cancer study.","authors":"Torgny Wessman, Toralph Ruge, Axel Carl Carlsson, Per Wändell, Ardavan Khoshnood, Olle Melander","doi":"10.1080/1354750X.2023.2298651","DOIUrl":"10.1080/1354750X.2023.2298651","url":null,"abstract":"<p><strong>Introduction: </strong>The aim was to evaluate two biomarker scores trained to identify comorbidity burden in the prediction of specified chronic morbidities, and mortality in the general population.</p><p><strong>Methods: </strong>Cardiovascular biomarkers were measured in the cardiovascular cohort of the Malmö Diet and Cancer Study. A score of 19 biomarkers associated with Charlson Comorbidity Index (CCI) was created (BSMDC). Individuals with CCI diagnoses and other major comorbidities were excluded. Another score of 11 biomarkers associated with comorbidity burden from a previous study of acute dyspnea was also created (BSADYS). The scores were prospectively evaluated for prediction of mortality, and some chronic diseases, using Cox Proportional Hazards Model.</p><p><strong>Results: </strong>Fully adjusted models showed that BSMDC was significantly associated per 1 SD increment of the score with incident COPD, 55%, and congestive heart failure, 32%; and with mortality, 33% cardiovascular, 91% respiratory, 30% cancer, and 45% with all-cause mortality. The BSADYS showed no association with these outcomes, after simultaneous inclusion of both biomarker scores to all the clinical covariates.</p><p><strong>Conclusion: </strong>BSMDC shows strong prediction of morbidity and mortality in individuals free from comorbidities at baseline, and the results suggest that healthy individuals with high level of BSMDC would benefit from intense preventive actions.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"722-730"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138828129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-01Epub Date: 2023-12-11DOI: 10.1080/1354750X.2023.2284109
Karashdeep Kaur, Rupinder Kaur
Background: Occupational pesticides exposure has raised health concerns due to genotoxicity and accumulation of DNA damage. Polymorphisms in genes encoding enzymes involved in nucleotide excision repair (NER) may affect the individual's susceptibility to pesticide toxicity.
Methods: This study evaluates the association of excision repair cross complementation group 1 (ERCC1) (8092 C > A, 3'UTR, rs3212986) and ERCC1 (19007 C > T, Asn118Asn, rs11615), ERCC4 (1244 G > A, Arg415Gln, rs1800067) and ERCC5 (3507 G > C, Asp1104His, rs17655) polymorphisms with pesticide-induced DNA damage in North-West Indian agricultural workers. The study population comprised 225 agricultural workers exposed to pesticides and 225 non-exposed controls.
Results: Our study demonstrate that exposed workers carrying variant ERCC1 8092AA genotype showed higher total comet DNA migration (p = 0.015) as well as increased frequency of cells showing DNA migration (p = 0.027). Exposed agricultural workers with variant ERCC4 1244AA (415Gln/Gln) and ERCC5 3507CC (1104His/His) genotypes exhibited elevation in total comet DNA migration (p < 0.01). However, genotypes of ERCC1 19007 C > T (Asn118Asn) showed no association with total comet DNA migration (p = 0.963), frequency of cells showing DNA migration (p = 0.423) as well as mean tail length (p = 0.432).
Conclusion: ERCC1, ERCC4 and ERCC5 polymorphisms influence DNA damage and can be used as biomarkers of susceptibility for pesticide-induced DNA damage in North-West Indian agricultural workers.
{"title":"Polymorphisms in <i>ERCC1, ERCC4</i> and <i>ERCC5</i> genes as biomarkers of susceptibility for pesticide-induced DNA damage in North-West Indian agricultural workers.","authors":"Karashdeep Kaur, Rupinder Kaur","doi":"10.1080/1354750X.2023.2284109","DOIUrl":"10.1080/1354750X.2023.2284109","url":null,"abstract":"<p><strong>Background: </strong>Occupational pesticides exposure has raised health concerns due to genotoxicity and accumulation of DNA damage. Polymorphisms in genes encoding enzymes involved in nucleotide excision repair (NER) may affect the individual's susceptibility to pesticide toxicity.</p><p><strong>Methods: </strong>This study evaluates the association of excision repair cross complementation group 1 (<i>ERCC1)</i> (8092 C > A, 3'UTR, rs3212986) and <i>ERCC1</i> (19007 C > T, Asn118Asn, rs11615)<i>, ERCC4</i> (1244 G > A, Arg415Gln, rs1800067) and <i>ERCC5</i> (3507 G > C, Asp1104His, rs17655) polymorphisms with pesticide-induced DNA damage in North-West Indian agricultural workers. The study population comprised 225 agricultural workers exposed to pesticides and 225 non-exposed controls.</p><p><strong>Results: </strong>Our study demonstrate that exposed workers carrying variant <i>ERCC1</i> 8092AA genotype showed higher total comet DNA migration (<i>p</i> = 0.015) as well as increased frequency of cells showing DNA migration (<i>p</i> = 0.027). Exposed agricultural workers with variant <i>ERCC4</i> 1244AA (415Gln/Gln) and <i>ERCC5</i> 3507CC (1104His/His) genotypes exhibited elevation in total comet DNA migration (<i>p</i> < 0.01). However, genotypes of <i>ERCC1</i> 19007 C > T (Asn118Asn) showed no association with total comet DNA migration (<i>p</i> = 0.963), frequency of cells showing DNA migration (<i>p</i> = 0.423) as well as mean tail length (<i>p</i> = 0.432).</p><p><strong>Conclusion: </strong><i>ERCC1, ERCC4</i> and <i>ERCC5</i> polymorphisms influence DNA damage and can be used as biomarkers of susceptibility for pesticide-induced DNA damage in North-West Indian agricultural workers.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"672-679"},"PeriodicalIF":2.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92152604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}